Prostaglandins and the regulation of sleep and wakefulness

Neurochemistry of Sleep and Wakefulness

Volumn , Issue , 2008, Pages 363-386

  Hayaishi, Osamu ^a   Urade, Yoshihiro ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862536799     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511541674.014     Document Type: Chapter

References (133)

1. Achen, M. G., et al. (1992). Protein synthesis at the blood-brain barrier. The major protein secreted by amphibian choroid plexus is a lipocalin. J. Biol. Chem. 267, 23170-4.
2. Basheer, R., et al. (2004). Adenosine and sleep-wake regulation. Prog. Neurobiol. 73, 79-96.
3. Beuckmann, C. T., et al. (2000). Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J. Comp. Neurol. 428, 62-78.
4. Bobillier, P., et al. (1982). Glucose utilization increases in choroid plexus during slow wave sleep. A [14C] deoxyglucose study in the cat. Brain Res. 240, 359-63.
5. Brettschneider, J., et al. (2004). Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus? J. Neurol. Neurosurg. Psychiatry 75, 1614-16.
6. Chan, P., et al. (1994). Comparative mapping of lipocalin genes in human and mouse: the four genes for complement C8 gamma chain, prostaglandin-D-synthase, oncogene-24p3, and progestagen-associated endometrial protein map to HSA9 and MMU2. Genomics 23, 145-50.
7. Christ-Hazelhof, E. & Nugteren, D. H. (1979). Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. Biochim. Biophys. Acta 572, 43-51.
8. Cipollone, F., et al. (2004). Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arteriosclerosis Thrombosis Vasc. Biol. 24, 1259-65.
9. Clausen, J. (1961). Proteins in normal cerebrospinal fluid not found in serum. Proc. Soc. Exp. Biol. Med. 107, 170-2.
10. Eguchi, Y., et al. (1997). Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc. Natl. Acad. Sci. USA 94, 14689-94.
11. Eguchi, N., et al. (1999). Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc. Natl. Acad. Sci. USA, 96, 726-30.
12. Eguchi, N., et al. (2002). Sleep in transgenic and gene-knockout mice for lipocalin-type prostaglandin D synthase. In Oxygen and Life: Oxygenases, Oxidases, and Lipid Mediators, ed. Y. Ishimura, M. Nozak, S. Yamamoto et al., International Congress Series 1233. Amsterdam: Elsevier Science, pp. 429-33.
13. Fouchecourt, S., et al. (2002a). Mammalian lipocalin-type prostaglandin D2 synthase in the fluids of the male genital tract: putative biochemical and physiological functions. Biol. Reprod. 66, 458-67.
14. Fouchecourt, S., et al. (2002b). Epididymal lipocalin-type prostaglandin D2 synthase: identification using mass spectrometry, messenger RNA localization, and immunodetection in mouse, rat, hamster, and monkey. Biol. Reprod. 66, 524-33.
15. Fredholm, B. B., et al. (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83-133.
16. Fredholm, B. B., et al. (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527-52.
17. Fujimori, K., et al. (2003). Regulation of lipocalin-type prostaglandin D synthase gene expression by Hes-1 through E-box and interleukin-1 beta via two NF-kappa B elements in rat leptomeningeal cells. J. Biol. Chem. 278, 6018-26.
18. Fujimori, K., et al. (2005). Protein kinase C activates human lipocalin-type prostaglandin D synthase gene expression through de-repression of notch-HES signaling and enhancement of AP-2 beta function in brain-derived TE671 cells. J. Biol. Chem. 280, 18452-61.
19. Fujitani, Y., et al. (2002). Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J. Immunol. 168, 443-9.
20. Gallopin, T., et al. (2005). The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience 134, 1377-90.
21. Garcia-Fernandez, L. F., et al. (2000). Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells. J. Neurochem. 75, 460-70.
22. Gerena, R. L., et al. (1998). Identification of a fertility-associated protein in bull seminal plasma as lipocalin-type prostaglandin D synthase. Biol. Reprod. 58, 826-33.
23. Gerena, R. L., et al. (2000a). Stage and region-specific localization of lipocalin-type prostaglandin D synthase in the adult murine testis and epididymis. J. Androl. 21, 848-54.
24. Gerena, R. L., et al. (2000b). Immunocytochemical localization of lipocalin-type prostaglandin D synthase in the bull testis and epididymis and on ejaculated sperm. Biol. Reprod. 62, 547-56.
25. Gerashchenko, D., et al. (1998). Dominant expression of rat prostanoid DP receptor mRNA in leptomeninges, inner segments of photoreceptor cells, iris epithelium, and ciliary processes. J. Neurochem. 71, 937-45.
26. Giessing, M. (1999). Beta-trace protein as indicator of glomerular filtration rate. Urology 54, 940-1.
27. Hamano, K., et al. (2002). Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients. Nephron 92, 77-85.
28. Hayaishi, O. (2005). Molecular mechanisms of sleep-wake regulation. In Sleep: Circuits and Functions, ed. P.-H. Luppi, Boca Raton, FL: CRC Press, pp. 65-82.
29. Hayaishi, O. & Huang, Z. L. (2004). Role of orexin and prostaglandin E2 in activating histaminergic neurotransmission. Drug News Perspec. 17, 105-9.
30. Hayaishi, O., et al. (2004). Genes for prostaglandin D synthase and receptor as well as adenosine A2A receptor are involved in the homeostatic regulation of nrem sleep. Arch. Ital. Biol. 142, 533-9.
31. Hervé, M., et al. (2003). Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur. J. Immunol. 33, 2764-72.
32. Hirai, H., et al. (2001). Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193, 255-61.
33. Hiraoka, A., et al. (1998). Sodium dodecyl sulfate-capillary gel electrophoretic analysis of molecular mass microheterogeneity of beta-trace protein in cerebrospinal fluid from patients with central nervous system diseases. J. Chromatogr. A 802, 143-8.
34. Hiraoka, A., et al. (2001). Charge microheterogeneity of the beta-trace proteins (lipocalin-type prostaglandin D synthase) in the cerebrospinal fluid of patients with neurological disorders analyzed by capillary isoelectrofocusing. Electrophoresis 22, 3433-7.
35. Hirata, M., et al. (1994). Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc. Natl. Acad. Sci. USA 91, 11192-6.
36. Hirawa, N., et al. (2001). Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus. Nephron 87, 321-7.
37. Hirawa, N., et al. (2002). Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension 39, 449-54.
38. Hiroshima, O., et al. (1986). Basal level of prostaglandin D2 in rat brain by a solid-phase enzyme immunoassay. Prostaglandins 32, 63-80.
39. Hoffmann, A., et al. (1993). Purification and chemical characterization of beta-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J. Neurochem. 61, 451-6.
40. Hoffmann, A., et al. (1994). Carbohydrate structures of beta-trace protein from human cerebrospinal fluid: evidence for "brain-type" N-glycosylation. J. Neurochem. 63, 2185-96.
41. Hoffmann, A., et al. (1997). Molecular characterization of beta-trace protein in human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology 7, 499-506.
42. Hong, Z. Y., et al. (2005). An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J. Neurochem. 92, 1542-9.
43. Huang, Z. L., et al. (2001). Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. USA 98, 9965-70.
44. Huang, Z. L., et al. (2003). Prostaglandin E2 activates the histaminergic system via EP4 receptor to induce wakefulness in rats. J. Neurosci. 23, 5975-83.
45. Huang, Z. L., et al. (2005). Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat. Neurosci. 8, 858-9.
46. Igarashi, M., et al. (1992). Structural organization of the gene for prostaglandin D synthase in the rat brain. Proc. Natl. Acad. Sci. USA 89, 5376-80.
47. Inoué, S. (1989). Biology of Sleep Substances. Boca Raton, FL: CRC Press.
48. Inui, T., et al. (2003). Characterization of the unfolding process of lipocalin-type prostaglandin D synthase. J. Biol. Chem. 278, 2845-52.
49. Irikura, D., et al. (2003). Cloning, expression, crystallization, and preliminary X-ray analysis of recombinant mouse lipocalin-type prostaglandin D synthase, a somnogen-producing enzyme. J. Biochem. 133, 29-32.
50. Irikura, D., et al. (2007). Characterization of a major secretory protein in the cane toad (Bufo marinus) choroid plexus as an amphibian lipocalin-type prostaglandin D synthase. J. Biochem. 141, 173-80.
51. Jordan, W., et al. (2004). Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep 27, 867-74.
52. Jouvet, M., et al. (1983). Serotonergic and nonserotonergic mechanisms in sleep. In Sleep Disorders; Basic and Clinical Research, ed. Gibson, C. J. and Chase, M. H., New York, NY: Spectrum, pp. 557-71.
53. Kanaoka, Y. & Urade, Y. (2003). Hematopoietic prostaglandin D synthase. Prostagland. Leukotrienes Essent. Fatty Acids 69, 163-7.
54. Koyama, Y. & Hayaishi, O. (1994). Modulation by prostaglandins of activity of sleep-related neurons in the preoptic/anterior hypothalamic areas in rats. Brain Res. Bull. 33, 367-72.
55. Kubata, B. K., et al. (2000). Identification of a novel prostaglandin F2α synthase in Trypanosoma brucei. J. Exp. Med. 192, 1327-38.
56. Kubata, B. K., et al. (2007). Molecular basis for prostaglandin production in hosts and parasites. Trends Parasitol. 23, 325-31.
57. Landolt, H. P., et al. (2004). Caffeine attenuates waking and sleep electroencephalographic markers of sleep homeostasis in humans. Neuropsychopharmacology 29, 1933-9.
58. Lee, B., et al. (2002). Prostaglandin D synthase in the prenatal ovine brain and effects of its inhibition with selenium chloride on fetal sleep/wake activity in utero. J. Neurosci. 22, 5679-86.
59. Lepperdinger, G., et al. (1996). The lipocalin X1cpll expressed in the neural plate of Xenopus laevis embryos is a secreted retinaldehyde binding protein. Protein Sci. 5, 1250-60.
60. Malki, S., et al. (2005). Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. EMBO J. 24, 1798-809.
61. Manya, H., et al. (2000). Comparative study of the asparagine-linked sugar chains of human lipocalin-type prostaglandin D synthase purified from urine and amniotic fluid, and recombinantly expressed in Chinese hamster ovary cells. J. Biochem. 127, 1001-11.
62. Mase, M., et al. (1999). Acute and transient increase of lipocalin-type prostaglandin D synthase (beta-trace) level in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage. Neurosci. Lett. 270, 188-90.
63. Mase, M., et al. (2003). Lipocalin-type prostaglandin D synthase (beta-trace) in cerebrospinal fluid: a useful marker for the diagnosis of normal pressure hydrocephalus. Neurosci. Res. 47, 455-9.
64. Matsumura, H., et al. (1988). Awaking effect of PGE2 microinjected into the preoptic area of rats. Brain Res. 444, 265-72.
65. Matsumura, H., et al. (1989). Awaking effect of prostaglandin E2 in freely moving rats. Brain Res. 481, 242-9.
66. Matsumura, H., et al. (1991). Inhibition of sleep in rats by inorganic selenium compounds, inhibitors of prostaglandin D synthase. Proc. Natl. Acad. Sci. USA 88, 9046-50.
67. Matsumura, H., et al. (1994). Prostaglandin D2-sensitive, sleep-promoting zone defined in the ventral surface of the rostral basal forebrain. Proc. Natl. Acad. Sci. USA 91, 11998-2002.
68. Melegos, D. N., et al. (1997). Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54, 463-74.
69. Melegos, D. N., et al. (1999). Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 53, 32-7.
70. Mignot, E., et al. (2002). Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat. Neurosci. 5 (Suppl.), 1071-5.
71. Miyagi, M., et al. (2005). Activator protein-1 mediates shear stress-induced prostaglandin d synthase gene expression in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25, 970-5.
72. Mizoguchi, A., et al. (2001). Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA 98, 11674-9.
73. Mong, J. A., et al. (2003a). Estradiol differentially regulates lipocalin-type prostaglandin D synthase transcript levels in the rodent brain: evidence from high-density oligonucleotide arrays and in situ hybridization. Proc. Natl. Acad. Sci. USA 100, 318-23.
74. Mong, J. A., et al. (2003b). Reduction of lipocalin-type prostaglandin D synthase in the preoptic area of female mice mimics estradiol effects on arousal and sex behavior. Proc. Natl. Acad. Sci. USA 100, 15206-11.
75. Morairty, S., et al. (2004). Disinhibition of ventrolateral preoptic area sleep-active neurons by adenosine: a new mechanism for sleep promotion. Neuroscience 123, 451-7.
76. Nagata, A., et al. (1991). Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophilic-ligand carrier proteins. Proc. Natl. Acad. Sci. USA 88, 4020-4.
77. Narumiya, S., et al. (1982). Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci. 31, 2093-103.
78. Oda, H., et al. (2002). Development and evaluation of a practical ELISA for human urinary lipocalin-type prostaglandin D synthase. Clin. Chem. 48, 1445-53.
79. Ogorochi, T., et al. (1984). Regional distribution of prostaglandins D2, E2, and E2 and related enzymes in postmortem human brain. J. Neurochem. 43, 71-82.
80. Okada, T., et al. (2003). Dominant localization of adenosine deaminase in leptomeninges and involvement of the enzyme in sleep. Biochem. Biophys. Res. Commun. 312, 29-34.
81. Onoe, H., et al. (1988). Prostaglandin D2, a cerebral sleep-inducing substance in monkeys. Proc. Natl. Acad. Sci. USA 85, 4082-6.
82. Otsuki, M., et al. (2003). Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Molec. Endocrinol. 17, 1844-55.
83. Pandey, H. P., et al. (1995). Concentration of prostaglandin D2 in cerebrospinal fluid exhibits a circadian alteration in conscious rats. Biochem. Molec. Biol. Int. 37, 431-7.
84. Pentreath, V. W., et al. (1990). The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Trans. R. Soc. Trop. Med. Hyg. 84, 795-9.
85. Pinzar, E., et al. (2000). Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA 97, 4903-7.
86. Priem, F., et al. (1999). Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin. Chem. 45, 567-8.
87. Qu, W. M., et al. (2006). Lipocalin-type prostaglandin D synthase prozduces prostaglandin D2 involved in regulation of physiological sleep. Proc. Natl. Acad. Sci. USA 103, 17949-54.
88. Ragolia, L., et al. (2003). Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells. J. Biol. Chem. 278, 22175-81.
89. Ragolia, L., et al. (2005). Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J. Biol. Chem. 280, 29946-55.
90. Rainnie, D. G., et al. (1994). Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science 263, 689-92.
91. Ram, A., et al. (1997). CSF levels of prostaglandins, especially the level of prostaglandin D2, are correlated with increasing propensity towards sleep in rats. Brain Res. 751, 81-9.
92. Rétey, J. V., et al. (2005). A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc. Natl. Acad. Sci. USA 102, 15676-81.
93. Roberts, J. L. II, et al. (1980). Increased production of prostaglandin D2 in patients with systemic mastocytosis. New Engl. J. Med. 303, 1400-4.
94. Rodriguez, C. M., et al. (2000). Expression of the lipocalin-type prostaglandin D synthase gene in the reproductive tracts of Holstein bulls. J. Reprod. Fert. 120, 303-9.
95. Samy, E. T., et al. (2000). Sertoli cell prostaglandin D2 synthetase is a multifunctional molecule: its expression and regulation. Endocrinology 141, 710-21.
96. Saper, C. B., et al. (2001). The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 24, 726-31.
97. Saper, C. B., et al. (2005). Hypothalamic regulation of sleep and circadian rhythms. Nature 437, 1257-63.
98. Satoh, S., et al. (1996). Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc. Natl. Acad. Sci. USA 93, 5980-4.
99. Satoh, S., et al. (1998). Involvement of adenosine A2A receptor in sleep promotion. Eur. J. Pharmacol. 351, 155-62.
100. Satoh, S., et al. (1999). Region-dependent difference in the sleep-promoting potency of an adenosine A2A receptor agonist. Eur. J. Neurosci. 11, 1587-97.
101. Scammell, T., et al. (1998). Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2. Proc. Natl. Acad. Sci. USA 95, 7754-9.
102. Scammell, T. E., et al. (2001). An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 107, 653-63.
103. Sherin, J. E., et al. (1996). Activation of ventrolateral preoptic neurons during sleep. Science 271, 216-19.
104. Shiki, Y., et al. (2004). Changes of lipocalin-type prostaglandin D synthase level during pregnancy. J. Obstet. Gynaecol. Res. 30, 65-70.
105. Shimamoto, S., et al. (2007). NMR solution structure of lipocalin-type prostaglandin D synthase: Evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity. J. Biol. Chem. (in press)
106. Shimizu, T., et al. (1979). Purification and properties of prostaglandin D synthetase from rat brain. J. Biol. Chem. 254, 5222-8.
107. Strecker, R. E., et al. (2000). Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav. Brain Res. 115, 183-204.
108. Taba, Y., et al. (2000). Fluid shear stress induces lipocalin-type prostaglandin D2 synthase expression in vascular endothelial cells. Circul. Res. 86, 967-73.
109. Takahata, Y., et al. (1993). Intravenous administration of inorganic selenium compounds, inhibitors of prostaglandin D synthase, inhibits sleep in freely moving rats. Brain Res. 623, 65-71.
110. Takeda, K., et al. (2006). Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF. Biochem. Biophys. Res. Commun. 339, 1098-106.
111. Tokugawa, Y., et al. (1998). Lipocalin-type prostaglandin D synthase in human male reproductive organs and seminal plasma. Biol. Reprod. 58, 600-7.
112. Tumani, H., et al. (1998). Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann. Neurol. 44, 882-9.
113. Ueno, R., et al. (1982). Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. Biochem. Biophys. Res. Commun. 109, 576-82.
114. Ueno, R., et al. (1983). Prostaglandin D2, a cerebral sleep-inducing substance in rats. Proc. Natl. Acad. Sci. USA 80, 1735-7.
115. Ujihara, M., et al. (1988). Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys. 260, 521-31.
116. Urade, Y. & Hayaishi, O. (2000a). Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim. Biophys. Acta 1482, 259-71.
117. Urade, Y. & Hayaishi, O. (2000b). Prostaglandin D synthase: structure and function. Vitam. Horm. 58, 89-120.
118. Urade, Y., et al. (1985). Purification and characterization of rat brain prostaglandin D synthetase. J. Biol. Chem. 260, 12410-15.
119. Urade, Y., et al. (1987a). Postnatal changes in the localization of prostaglandin D synthetase from neurons to oligodendrocytes in the rat brain. J. Biol. Chem. 262, 15132-6.
120. Urade, Y., et al. (1987b). Biochemical and immunological characterization of rat spleen prostaglandin D synthetase. J. Biol. Chem. 262, 3820-5.
121. Urade, Y., et al. (1989). Primary structure of rat brain prostaglandin D synthetase deduced from cDNA sequence. J. Biol. Chem. 264, 1041-5.
122. Urade, Y., et al. (1990). Mast cells contain spleen-type prostaglandin D synthetase. J. Biol. Chem. 265, 371-5.
123. Urade, Y., et al. (1993). Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc. Natl. Acad. Sci. USA 90, 9070-4.
124. Urade, Y., et al. (2002). Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediators 68-9, 375-82.
125. Urade, Y., et al. (2003). Sleep regulation in adenosine A2A receptor-deficient mice. Neurology 61, S94-6.
126. Urade, Y., et al. (2006a). Lipocalin-type prostaglandin D synthase as an enzymic lipocalin. In Lipocalins, ed. B. Åkersröm, N. Borregaard, D. R. Flower & J-P, Salier. Georgetown, TX: Eurekah, pp. 99-109.
127. Urade, Y., et al. (2006b). Biochemical and structural characteristics of hematopoietic prostaglandin D synthase: from evolutionary analysis to drug designing. Functional and Structural Biology on the Lipo-network, 2006, Transworld Research Network, Kerala, India, pp. 135-64.
128. Watanabe, K., et al. (1994). Identification of beta-trace as prostaglandin D synthase. Biochem. Biophys. Res. Commun. 203, 1110-16.
129. White, D. M., et al. (1992). Structure and chromosomal localization of the human gene for a brain form of prostaglandin D2 synthase. J. Biol. Chem. 267, 23202-8.
130. White, D. M., et al. (1997). Beta-trace gene expression is regulated by a core promoter and a distal thyroid hormone response element. J. Biol. Chem. 272, 14387-93.
131. Yamashima, T., et al. (1997). Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process. J. Neurosci. 17, 2376-82.
132. Yamashita, A., et al. (1983). Autoradiographic localization of a binding protein(s) specific for prostaglandin D2 in rat brain. Proc. Natl. Acad. Sci. USA 80, 6114-18.
133. Zhu, H., et al. (2004). Expression and regulation of lipocalin-type prostaglandin D synthase in rat testis and epididymis. Biol. Reprod. 70, 1088-95.